Tuesday, October 7, 2025

Latest

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”. The firm’s initial public offering is looking to raise US$204.0 million and is expected to close on September 17, 2021.

The offering will be conducted through the issuance of 12.0 million common shares selling at US$17.00 per share. This is an adjustment from the company’s original plan to issue 10.0 million shares with share price expectations between US$15.00 and US$17.00.

The company granted the underwriters a 30-day over-allotment option to purchase additional 1.8 million common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. BofA Securities, SVB Leerink, and Evercore ISI are all acting as joint bookrunners for the said offering.

The California-based biotech firm is in the business of developing immunotherapies for patients with chronic diseases. Currently, the firm’s lead therapeutic candidate S011806 is an oral antagonist targeting a pro-inflammatory signaling molecule connected with a variety of immunology indications. The orally-available candidate is expected to enter its phase 1 trial in the second half of 2021.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Venture Capital-Backed SPAC Banner Acquisition Eyes US$150 Million IPO

Special purpose acquisition company Banner Acquisition Corp. (Nasdaq: BNNRU) started trading publicly yesterday on the...

Thursday, September 9, 2021, 12:44:00 PM

Apparel Brand Allbirds Prices US$303 Million IPO

Footwear and apparel brand Allbirds, Inc. (Nasdaq: BIRD) started trading on the Nasdaq Global Select...

Wednesday, November 3, 2021, 02:17:00 PM

Clean Transition SPAC Monterey Capital Acquisition Prices Downsized US$80 Million IPO

Special purpose acquisition company Monterey Capital Acquisition Corporation (Nasdaq: MCACU) started trading its securities on...

Wednesday, May 11, 2022, 02:19:00 PM

Coinbase: The IPO Deep Dive

Coinbase Global (NASDAQ: COIN) is one of the hottest deals coming to market in 2021...

Tuesday, April 13, 2021, 01:30:00 PM

Fintech SPAC World Quantum Growth Acquisition Prices Downsized US$200 Million IPO

Blank check company World Quantum Growth Acquisition Corp. (NYSE: WQGA.U) went public yesterday on the...

Thursday, August 12, 2021, 04:37:00 PM